New Software to Predict Cell Activity for Cancer Research
Researchers have developed a method to predict the cell activity in tissues over time. The method involves new software that combines genomics technologies with...
FDA Accepts BLA for Recommended Biosimilar to Simponi
Bio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi® (golimumab). The FDA goal...
Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug
Merck to acquire Verona Pharma, a UK-based pharmaceutical company in a $10 billion acquisition, adding the promising respiratory drug Ohtuvayre into its pipeline as...
ChiRhoClin, LogiCare3PL Partners for Drug Distribution
LogiCare3PL, a division of BioCare, Inc., has announced a partnership with ChiRhoClin, Inc., a recognized leader in pancreatic and gastrointestinal diagnostics. This strategic move...
Thermo Fisher and Sanofi Partners for US Drug Manufacturing
Thermo Fisher Scientific announced an expansion plan with its strategic partnership with Sanofi that will enable additional US drug product manufacturing. The terms of...
EMA Recommendations to Secure Anti-D Immunoglobulins Supply
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have issued recommendations through the Executive Steering Group on Shortages and Safety...
FDA Approves Oral Therapy for Treating Hereditary Angioedema
The US Food and Drug Administration (FDA) has approved the first on-demand oral therapy for the treatment of acute attacks of hereditary angioedema (HAE)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...